Immunosuppressive Drugs
National · Effective Jan 1, 2026
1 active Medicare policy lists J7515, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 1, 2026
6 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7515 |
|---|---|---|
| Alopecia Areata | Feb 16, 2024 | Covered |
| Extracorporeal Immunoadsorption (Prosorba Column) | Jun 5, 2023 | Covered |
| Policy | Effective | Status of J7515 |
|---|---|---|
| Restasis (cyclosporine 0.05% ophthalmic emulsion) (PG025, Ver. 8) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Verkazia (cyclosporine ophthalmic emulsion) 0.1% (PG236, Ver. 2) |
| Not recorded |
| Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7515 |
|---|---|---|
| Cyclosporine (Cequa, Restasis, Verkazia, Vevye, Klarity-C); CP.PMN.48 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7515 |
|---|---|---|
| 00802 Verkazia (cyclosporine ophthalmic emulsion) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |